Allen JM, Raine AEG, Ledingham JEG, Bloom SR (1985) Neuropeptide Y: a novel renal peptide with vasoconstrictor and natriuretic activity. Clin Sci 68:373–377
PubMed
CAS
Google Scholar
Bell C, Lang WJ (1973) Neural dopaminergic vasodilatation control in kidney. Nature 246:27–29
CAS
Google Scholar
Bomzon A (1983) Sympathetic control of the renal circulation. J Auton Pharmacol 3:37–46
PubMed
CAS
Google Scholar
Börner H, Klinkmann H (1980) Pathogenesis of acute non-inflammatory renal failure. Nephron 25:261–266
PubMed
Google Scholar
Bowmer CJ, Collis MG, Yates MS (1986) Effect of the adenosine antagonit 8-phenyltheophylline on glycerol-induced acute renal failure in rat. Br J Pharmacol 88:205–212
PubMed
CAS
Google Scholar
Carroll R, Kovacs K, Tapp E (1965) The pathogenesis of glycerol-induced renal tubular necrosis. J Pathol Bacteriol 89:537–580
Google Scholar
Cheng JT, Shen CL (1987) Release of neuropeptide Y(NPY) induced by tyramine in the isolated vas deferens of rat. Naunyn-Schmiedeberts Arch Pharmacol 335:255–260
CAS
Google Scholar
Gray TS, Morley JE (1986) Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sci 38:389–401
PubMed
Article
CAS
Google Scholar
Hsu CH, Kurtz TW, Waldinger TP (1977) Cardiac output and renal blood flow in glycerol-induced acute renal failure in the rat. Circ Res 40:178–182
PubMed
CAS
Google Scholar
Kebabian JW, Calne DB (1970) Multiple receptors for dopamine. Nature 277:93–96
Article
Google Scholar
Levy MN (1971) Sympathetic-parasympathetic interactions in the heart. Circ Res 29:437–443
PubMed
CAS
Google Scholar
Lokhandwala MF, Barrett RJ (1982) Cardiovascular dopamine receptors: physiological, pharmacological and therapeutic implications. J Auton Pharmacol 3:189–215
Google Scholar
Lundberg JM, Tatemoto K (1982) Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha adrenoceptor blockade. Acta Physiol Scand 116:393–402
PubMed
CAS
Google Scholar
Lundberg JM, Terenius L, Hökfelt T, Goldstein M (1983) High levels of neuropeptide Y in peripheral noradrenergic neurons in various mammals including man. Neurosci Lett 42:167–172
PubMed
Article
CAS
Google Scholar
Maruyama Y, Oshima T, Nakajima E (1980) Simultaneous determination of catecholamines in rat brain by reversed-phase liquid chromatography with electrochemical detection. Life Sci 26:1115–1120
PubMed
Article
CAS
Google Scholar
Mitchell GAG (1950) The nerve supply of the kidney. Acta Anat (Basel) 10:1–37
CAS
Google Scholar
Pernow J, Thorén P, Millberg BI, Lundberg JM (1988) Renal sympathetic nerve activation in relation to reserpine-induced depletion of neuropeptide Y in the kidney of the rat. Acta Physiol Scand 134:53–59
PubMed
CAS
Article
Google Scholar
Schmidt M, Krieger JP, Giesen-Crouse EM, Imbs JL (1987) Vascular effects of selective dopamine receptor agonists and antagonists in the rat kidney. Arch Int Pharmacodyn ther 286:195–205
PubMed
CAS
Google Scholar
Shen CL, Cheng JT (1989) Cross-reaction of FMRFamide with a neuropeptide Y(NPY) antiserum: histological and radioimmunochemical evidence. Biomed Res 10:517–520
CAS
Google Scholar
Stein JH, Lifschitz MD, Barnes LD (1978) Current concepts on pathophysiology of acute renal failure. Am J Physil 234:F171-F181
CAS
Google Scholar
Tatemoto K, Carlquist M, Mutt V (1982) Neuropeptide Y—a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature 296:659–660
PubMed
Article
CAS
Google Scholar
Theodorsson-Norheim E, Hemsén A, Lundberg JM (1985) Radioimmunoassay for neuropeptide Y(NPY): chromatographic characterization of immunoreactivity in plasma and tissue extract. J Clin Lab Invest 45:355–365
CAS
Article
Google Scholar